Collegium Pharmaceutical, Inc. COLL
24.21 USD -0.95 (-3.78%)
At closeNov 9, 2026, 4:42 AM EST
24.39 +0.18 +0.74%
Pre-market · Nov 9, 4:42 AM ET
23.71 Day range 24.80
21.43 52-week range 50.79
- YTD
- -47.71%
- 1 year
- -40.46%
COLL revenue history
Revenue is income from the company’s ordinary business activities.
780,567,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 780,567,000 | 149,118,000 | 23.62% |
| FY 2024 | 2024-12-31 | 631,449,000 | 64,682,000 | 11.41% |
| FY 2023 | 2023-12-31 | 566,767,000 | 102,834,000 | 22.17% |
| FY 2022 | 2022-12-31 | 463,933,000 | 187,065,000 | 67.56% |
| FY 2021 | 2021-12-31 | 276,868,000 | -33,148,000 | -10.69% |
| FY 2020 | 2020-12-31 | 310,016,000 | 13,315,000 | 4.49% |
| FY 2019 | 2019-12-31 | 296,701,000 | 16,288,000 | 5.81% |
| FY 2018 | 2018-12-31 | 280,413,000 | 251,937,000 | 884.73% |
| FY 2017 | 2017-12-31 | 28,476,000 | 26,765,000 | 1564.29% |
| FY 2016 | 2016-12-31 | 1,711,000 | 1,711,000 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:15.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.